Abattis Bioceuticals Corp. (ATTBF)

[GreenBrickRoad]

Hate to put it this way, but you could argue that ATTBF has gone up with Emerald at a similar rate, when you factor in all the dilution in the past month from the PP's and the Green Tree Therapeutics acquisition. Not saying we won't benefit from these deals in the long-run, but in the short-run, the share price of OTC companies almost always suffers when they roll out the share printing press.